Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP)
NRXP Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
235.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
NRXP Stock Analysis
NRXP
PE Ratio:
NRXP
PEG Ratio:
NRXP
Forward EPS Growth (12 month):
205.00%
NRXP
PS Ratio:
30.5
NRXP
PSG Ratio:
0.1
NRXP
Forward Revenue Growth (12 month):
276.40%
NRXP Articles
No data was found